Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Obsessive-Compulsive Disorder Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

57 recruiting trials for Obsessive-Compulsive Disorder. Eligibility criteria explained in plain English.

TrialFinderData lists 57 Obsessive-Compulsive Disorder clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 2 is the largest group at 63% (5 studies); the largest phase groups are Phase 2: 5, Phase 1 / Phase 2: 2, Phase 1: 1.

Research is led by Mclean Hospital (3), Shanghai Mental Health Center (2), Medical University of Vienna (2), among the most active sponsors registered for these trials.

The most frequently studied intervention is deep brain stimulation (device, 5 trials), followed by Ketamine, Repetitive Transcranial Magnetic Stimulation (rTMS).

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
57
Total Trials
57
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Track Obsessive-Compulsive Disorder trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00575081

Physiological Brain Atlas Development

The NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data...

Sponsor: Vanderbilt University Medical CenterEnrolling: 50001 location
RECRUITINGNCT06585618

A Multicenter Pediatric Deep Brain Stimulation Registry

There is limited data on outcomes for children who have undergone deep brain stimulation (DBS) for movement disorders, and individual centers performing this surgery often lack...

Sponsor: Boston Children's HospitalEnrolling: 1001 location
RECRUITINGNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD). These...

Sponsor: Mark NiciuEnrolling: 10001 location
RECRUITINGNCT01635569

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications...

Sponsor: University of British ColumbiaEnrolling: 1801 location
RECRUITINGNCT06346301

Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.

The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD)....

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 361 location
RECRUITINGNCT05467683

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a...

Sponsor: Jasper A. SmitsEnrolling: 6002 locations
RECRUITINGNCT04730011

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from...

Sponsor: Susanne WalitzaEnrolling: 1001 location
RECRUITINGNCT04631042

Developing Brain, Impulsivity and Compulsivity

Background: Impulsivity is acting 'without thinking.' Compulsivity is being overly inflexible. People vary in how impulsive or compulsive they are. Extreme versions of these...

Sponsor: National Institute of Mental Health (NIMH)Enrolling: 11001 location
RECRUITINGNCT07031544

Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive...

The goal of this clinical trial is to evaluate the efficacy and influencing factors of the combination of the anterior limb of internal capsule and nucleus accumbens (ALIC-NAc)...

Sponsor: Shanghai Mental Health CenterEnrolling: 6010 locations
RECRUITINGNCT05712057

Neurostimulation Versus Therapy for Problems With Emotions

The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with...

Sponsor: Duke UniversityEnrolling: 2401 location
RECRUITINGNCT06443125

Study on Therapeutic Mechanism of Natural Psychotherapy for Neurosis

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Sponsor: Xiang Yang ZhangEnrolling: 502 locations
RECRUITINGNCT07198594

Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder

The goal of this clinical trial is to learn if individualized accelerated repetitive transcranial magnetic stimulation (rTMS) targeting the inferior frontal cortex combined with...

Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji UniversityEnrolling: 201 location
RECRUITINGNCT06173752

Mechanisms of Exposure Therapy for OCD

Exposure therapy is the most effective treatment available for obsessive compulsive disorder, yet up to 50% of patients do not recover because the mechanisms underlying successful...

Sponsor: Mclean HospitalEnrolling: 4002 locations
RECRUITINGNCT05377125

Neural Mechanisms of Response Inhibition Training for OCRD

The impaired ability to suppress an inappropriate but pre-potent response (response inhibition; RI) characterizes several debilitating clinical problems, including...

Sponsor: University of Wisconsin, MilwaukeeEnrolling: 1181 location
RECRUITINGNCT05577585

Ketamine in OCD: Efficacy and Effects on Stress and Cognition

The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours...

Sponsor: Medical University of ViennaEnrolling: 601 location
RECRUITINGNCT05048251

Individually Targeted Neuromodulation for Contamination-based OCD

Patients with obsessive-compulsive disorder (OCD) experience a wide array of different types of obsessions and compulsions. However, current treatments for OCD employ a "one size...

Sponsor: Mclean HospitalEnrolling: 501 location
RECRUITINGNCT02537795

Psychiatric Neurosurgery (PNS) for Obsessive Compulsive Disorder (OCD): A Qualitative Analysis of Patient and Family...

In this study the investigators will use semi-structured interviews to qualitatively analyse patient and family member experiences with either deep brain stimulation or other...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 401 location
RECRUITINGPhase 2NCT05783817

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

The study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).

Sponsor: Carolyn RodriguezEnrolling: 401 location
RECRUITINGNCT06494735

Effect of the French Version If the Metagognitive Bibliotherapy Program "MYMCT" on Obsessive-compulsive Symptoms

Obsessive-compulsive disorder (OCD) is a psychiatric illness characterized by the presence of obsessions and/or compulsions. Without effective treatment, symptoms tend to worsen...

Sponsor: Centre Hospitalier Universitaire de NiceEnrolling: 1141 location
RECRUITINGPhase 1 / Phase 2NCT06575075

Pilot Study of RR-HNK in OCD

The purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.

Sponsor: Carolyn RodriguezEnrolling: 451 location
RECRUITINGPhase 2NCT06611592

Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD)

The most common and effective treatment for OCD is pharmacological therapy that includes selective serotonin reuptake inhibitors (SSRIs) antidepressants and, in the case of...

Sponsor: Clinical Academic Center (2CA-Braga)Enrolling: 481 location
RECRUITINGNCT07245134

Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients

The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly...

Sponsor: National Institute of Mental Health, Czech RepublicEnrolling: 621 location
RECRUITINGPhase 2NCT05940324

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

Sponsor: Stanford UniversityEnrolling: 1501 location
RECRUITINGNCT06582225

ICBT for OCD in Children With Autism

The purpose of this trial is to evaluate the clinical efficacy, the cost-effectiveness and the effect durability of a therapist-guided, internet-delivered cognitive-behavior...

Sponsor: Karolinska InstitutetEnrolling: 2203 locations
RECRUITINGNCT06942494

Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD

The goal of this clinical trial is to learn if self-help book can be used to treat obsessive-compulsive disorder (OCD) in adolescents aged 10 to 17. The main questions it aims to...

Sponsor: Shanghai Mental Health CenterEnrolling: 881 location
RECRUITINGNCT06542224

Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation

Obsessive-compulsive disorder (OCD) is a complex and severe mental illness characterized by multiple symptoms and is considered a leading cause of non-fatal health loss. However,...

Sponsor: West China HospitalEnrolling: 164 locations
RECRUITINGPhase 2NCT04882839

Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD

Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder characterized by recurrent distressing thoughts and substantial anxiety, accompanied by repetitive behaviors or...

Sponsor: Beersheva Mental Health CenterEnrolling: 151 location
RECRUITINGNCT06621381

Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder

The goal of this clinical trial is to evaluate the preliminary outcomes of concentrated exposure and response prevention for children with obsessive-compulsive disorder (OCD) in...

Sponsor: Uppsala University HospitalEnrolling: 201 location
RECRUITINGNCT05995951

Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder

This study will include two parts. The first part will include two patients in a non-blinded, non-randomized, open trial. They will undergo Deep Bran Stimulation (DBS) for OCD...

Sponsor: Rabin Medical CenterEnrolling: 101 location
RECRUITINGNCT07146438

Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder

This study will test how people with OCD respond to a type of noninvasive brain stimulation, repetitive Transcranial Magnetic Stimulation (rTMS), when it is combined with...

Sponsor: Adam FrankEnrolling: 481 location
RECRUITINGNCT03953014

Pharmacogenetics of Antidepressant-Induced Disinhibition

The purpose of this study is to identify pharmacogenetic profiles associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioral disinhibition in children with...

Sponsor: University of CalgaryEnrolling: 1201 location
RECRUITINGNCT06660225

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder

The goal of this clinical trial is to learn if deep brain stimulation (DBS) works to treat refractory obsessive-compulsive disorder (OCD). The main questions it aims to answer...

Sponsor: Nader PouratianEnrolling: 101 location
RECRUITINGNCT04934007

Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder

According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in...

Sponsor: Centre Hospitalier Henri LaboritEnrolling: 1362 locations
RECRUITINGPhase 1NCT07347405

Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

The study tries to improve our treatments for people who have obsessive-compulsive disorder (OCD) by testing psilocybin, a mind altering drug that changes activity in brain areas...

Sponsor: Francisco A MorenoEnrolling: 301 location
RECRUITINGNCT05881356

Discovering Factors in the Clinical Study Journey of Patients With OCD

This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or...

Sponsor: Power Life Sciences Inc.Enrolling: 5001 location
RECRUITINGNCT05577598

Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder

The purpose of this randomized, sham-controlled study is to evaluate the effectiveness of DBS therapy in individuals suffering from severe OCD and to investigate DBS treatment...

Sponsor: Medical University of ViennaEnrolling: 81 location
RECRUITINGNCT07158801

Project EMPOWER-OCD

This research study aims to adapt and evaluate the acceptability and effectiveness of Project EMPOWER-OCD for socioeconomically diverse caregivers of patients with OCD. Designed...

Sponsor: Boston University Charles River CampusEnrolling: 1101 location
RECRUITINGNCT07135414

Accelerated rTMS in Hospitalized Patients With OCD: a Feasibility and Mechanistic Study

This study investigates a new treatment approach for Obsessive-Compulsive Disorder (OCD), a condition characterized by unwanted repetitive thoughts and behaviors. The goal is to...

Sponsor: University Hospital, GhentEnrolling: 601 location
RECRUITINGNCT05224414

Interpretation Bias as a Mechanism of Treatment Response in OCD

This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive...

Sponsor: Mclean HospitalEnrolling: 1061 location
RECRUITINGNCT06017713

tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder

This is a single-center study about patients with severe resistant OCD. Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right...

Sponsor: Centre Hospitalier Henri LaboritEnrolling: 251 location
RECRUITINGNCT04900064

Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial

In this multicenter study, the investigators want to find out if an addition of an diagnostic assessment and possibility of treatment with guided self-help CBT can increase the...

Sponsor: Linnaeus UniversityEnrolling: 12424 locations
RECRUITINGNCT05651295

A Precision Medicine Approach to Target Engagement for Emotion Regulation

The proposed study is designed to first test whether teaching people personalized or standardized emotion regulation skills leads to greater decreases in daily negative emotion...

Sponsor: Matthew Southward, PhDEnrolling: 3901 location
RECRUITINGNCT07116785

Accelerated Rotational Field Deep TMS for Treating OCD

A Prospective Double Blind Randomized Controlled Trial to Evaluate the Efficacy and Durability of the BrainsWay Rotational Field Deep Transcranial Magnetic Stimulation (Deep TMS)...

Sponsor: Ben-Gurion University of the NegevEnrolling: 501 location
RECRUITINGNCT06628752

Deep Brain Stimulation for Obsessive-compulsive Disorder

The goal of this clinical trial is to evaluate the treatment method of deep brain stimulation (DBS) in patients diagnosed with severe and treatment-resistant obsessive-compulsive...

Sponsor: Umeå UniversityEnrolling: 261 location
RECRUITINGNCT07622654

Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity

This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity....

Sponsor: Mehmet Emrah KaradereEnrolling: 361 location
RECRUITINGNCT06917339

Retrospective Analyses of TrakStar Database

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar...

Sponsor: NeuroneticsEnrolling: 1560001 location
RECRUITINGNCT06490965

Improving Obsessive-compulsive Disorder Treatments: from Lesions to Neuromodulation Targets

While in most cases of obsessive-compulsive disorder (OCD) a cause cannot be identified, this syndrome may develop as a consequence of focal brain lesions. Neuropsychiatric...

Sponsor: Fundacao ChampalimaudEnrolling: 321 location
RECRUITINGPhase 1 / Phase 2NCT04131829

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines,...

Sponsor: Yale UniversityEnrolling: 1001 location
RECRUITINGPhase 2NCT03826693

Efficacy of Nitrous Oxide in OCD: Pilot Study

This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.

Sponsor: Stanford UniversityEnrolling: 451 location
RECRUITINGNCT06724029

Neurosurgical Outcome Network

The evaluation of neurosurgical outcomes varies from center to center, and the predictive factors that determine these outcomes are not fully known or shared. This study aims to...

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaEnrolling: 450020 locations

Showing 50 of 57 trials.Search all Obsessive-Compulsive Disorder trials

Frequently Asked Questions

There are currently 57 clinical trials for Obsessive-Compulsive Disorder, with 57 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Obsessive-Compulsive Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Obsessive-Compulsive Disorder, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.